NEW YORK (GenomeWeb News) – Affymetrix today said that it has signed a co-marketing agreement with GenoSplice naming the Evry, France-based bioinformatics firm as its preferred data analysis service provider for the GeneChip Human Transcriptome Array 2.0.
Affy noted that GenoSplice's Easana expression analysis product, which can analyze data from the firm's microarrays including its GeneChip Exon 1.0 ST Array, the GeneChip Human Transcriptome Array 1.0 and the newer GeneChip Human Transcriptome Array 2.0.
"As part of Affymetrix's commitment to provide end-to-end solutions, we are enabling those without access to bioinformatics to utilize the most powerful microarrays ever developed for the interrogation of alternative splicing events," Kevin Cannon, SVP of the expression business unit at Affy, said in a statement.
Further terms of the alliance were not disclosed.